Actively Recruiting
Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment
Led by University Ghent · Updated on 2024-05-06
450
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
Sponsors
U
University Ghent
Lead Sponsor
U
University Hospital, Ghent
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Montreal Cognitive Assessment (MoCA) is a screening test for detecting cognitive impairment that assesses several cognitive domains (attention and concentration, arithmetic and orientation, memory, etc.). The instructions as well as some test items of the MoCA are presented auditory (spoken). Consequently, performance on the MoCA may be co-dependent on hearing. Therefore, to rule out the possible negative influence of hearing loss on performance on the MoCA, a MoCA for individuals with hearing loss was recently developed. More specifically, the original MoCA was modified by providing the instructions audiovisually (spoken with visual support) as well as by replacing hearing-dependent items. Since replacing items may affect sensitivity and specificity, the MoCA for persons with hearing loss should be revalidated.
CONDITIONS
Official Title
Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals aged 60 years or older
- Individuals with normal vision (with lenses or glasses if needed)
- Individuals with age-related hearing loss
- Dutch-speaking individuals
- Individuals capable of giving consent to participate in the study themselves
- Individuals still residing in their own homes
- Individuals with an official diagnosis of dementia (Alzheimer's, vascular, or mixed) or mild cognitive impairment. This inclusion criterion applies only to the group with cognitive impairment.
You will not qualify if you...
- For individuals without cognitive impairment: history of neurological problems (brain tumor, epilepsy, history of stroke, etc.)
- For individuals without cognitive impairment: use of influencing medication (e.g., Ritalin and antidepressants)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Ghent Hospital
Ghent, East-Flanders, Belgium, 9000
Actively Recruiting
Research Team
K
Katrien Kestens, PhD
CONTACT
T
Tim Van Langenhove, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here